Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure.

Taylor BJ, Mojica CR, Olson TP, Woods PR, Frantz RP, Johnson BD.

J Card Fail. 2013 Jan;19(1):50-9. doi: 10.1016/j.cardfail.2012.11.005.

2.

Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.

Tedford RJ, Beaty CA, Mathai SC, Kolb TM, Damico R, Hassoun PM, Leary PJ, Kass DA, Shah AS.

J Heart Lung Transplant. 2014 Mar;33(3):289-97. doi: 10.1016/j.healun.2013.11.008. Epub 2013 Nov 28.

3.

Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure.

Aronson D, Eitan A, Dragu R, Burger AJ.

Circ Heart Fail. 2011 Sep;4(5):644-50. doi: 10.1161/CIRCHEARTFAILURE.110.960864. Epub 2011 May 23. Erratum in: Circ Heart Fail. 2012 Jan 1;5(1):e18.

4.

Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.

Farrero M, Blanco I, Batlle M, Santiago E, Cardona M, Vidal B, Castel MA, Sitges M, Barbera JA, Perez-Villa F.

Circ Heart Fail. 2014 Sep;7(5):791-8. doi: 10.1161/CIRCHEARTFAILURE.113.000942. Epub 2014 Jul 21.

5.

Characterization of patients with borderline pulmonary arterial pressure.

Kovacs G, Avian A, Tscherner M, Foris V, Bachmaier G, Olschewski A, Olschewski H.

Chest. 2014 Dec;146(6):1486-93. doi: 10.1378/chest.14-0194.

PMID:
25451346
6.

Submaximal Exercise Pulmonary Gas Exchange in Left Heart Disease Patients With Different Forms of Pulmonary Hypertension.

Taylor BJ, Smetana MR, Frantz RP, Johnson BD.

J Card Fail. 2015 Aug;21(8):647-55. doi: 10.1016/j.cardfail.2015.04.003. Epub 2015 Apr 14.

7.

Exercise ventilatory parameters for the diagnosis of reactive pulmonary hypertension in patients with heart failure.

Lim HS, Theodosiou M.

J Card Fail. 2014 Sep;20(9):650-7. doi: 10.1016/j.cardfail.2014.06.355. Epub 2014 Jun 18.

PMID:
24951933
8.

Pulmonary hypertension in patients with advanced heart failure is associated with increased levels of interleukin-6.

Dolenc J, Šebeštjen M, Vrtovec B, Koželj M, Haddad F.

Biomarkers. 2014 Aug;19(5):385-90. doi: 10.3109/1354750X.2014.918654. Epub 2014 May 15.

PMID:
24831174
9.

The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease.

Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ.

JACC Heart Fail. 2015 Jan;3(1):9-16. doi: 10.1016/j.jchf.2014.07.010. Epub 2014 Nov 12.

10.

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.

Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R.

Circulation. 1992 Feb;85(2):504-9. Erratum in: Circulation 1993 Mar;87(3):1064.

PMID:
1735147
11.

Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation.

Baughman RP, Engel PJ, Taylor L, Lower EE.

Chest. 2010 Nov;138(5):1078-85. doi: 10.1378/chest.09-2002. Epub 2010 Mar 26.

PMID:
20348196
12.

Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.

Valerio CJ, Schreiber BE, Handler CE, Denton CP, Coghlan JG.

Arthritis Rheum. 2013 Apr;65(4):1074-84. doi: 10.1002/art.37838.

13.

The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study.

Reichenbach A, Al-Hiti H, Malek I, Pirk J, Goncalvesova E, Kautzner J, Melenovsky V.

Int J Cardiol. 2013 Sep 20;168(1):60-5. doi: 10.1016/j.ijcard.2012.09.074. Epub 2012 Oct 8.

PMID:
23058346
14.

Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease.

Tatebe S, Fukumoto Y, Sugimura K, Miyamichi-Yamamoto S, Aoki T, Miura Y, Nochioka K, Satoh K, Shimokawa H.

Circ J. 2012;76(5):1235-44. Epub 2012 Feb 7.

15.

Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity.

Allen SW, Chatfield BA, Koppenhafer SA, Schaffer MS, Wolfe RR, Abman SH.

Am Rev Respir Dis. 1993 Aug;148(2):519-22.

PMID:
8342919
16.

Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.

von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M; PROPHET Study Group..

J Heart Lung Transplant. 2006 Sep;25(9):1070-6. Epub 2006 Jul 18.

PMID:
16962468
17.

Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation.

Hefke T, Zittermann A, Fuchs U, Schulte-Eistrup S, Gummert JF, Schulz U.

Thorac Cardiovasc Surg. 2012 Feb;60(1):26-34. doi: 10.1055/s-0030-1250726. Epub 2011 Mar 22.

PMID:
21432755
18.

Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.

Gerges M, Gerges C, Pistritto AM, Lang MB, Trip P, Jakowitsch J, Binder T, Lang IM.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1234-46. doi: 10.1164/rccm.201503-0529OC.

PMID:
26181215
19.

Pulmonary artery diastolic pressure gradient as an indicator of severity of illness in patients with pulmonary hypertension related to left-sided heart disease.

Howard C, Rangajhavala K, Safdar Z.

Ther Adv Respir Dis. 2015 Apr;9(2):35-41. doi: 10.1177/1753465815573373. Epub 2015 Feb 25.

PMID:
25721948
20.

Supplemental Content

Support Center